Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
$99.54
-5.21-4.97%
Last update: Jan 15, 12:03 PM
Comments
Loading...
Edge Rankings
Stock Score Locked: Want to See it?
Benzinga Rankings give you vital metrics on any stock – anytime.
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy GRAIL (GRAL) stock?
You can purchase shares of GRAIL (NASDAQ:GRAL) through any online brokerage.
Who are GRAIL (GRAL) competitors?
Other companies in GRAIL’s space includes: IDEAYA Biosciences Inc (NASDAQ:IDYA), Legend Biotech Corp (NASDAQ:LEGN), Celcuity Inc (NASDAQ:CELC), Centessa Pharmaceuticals PLC (NASDAQ:CNTA) and Arcutis Biotherapeutics Inc (NASDAQ:ARQT).
What is the forecast, or price target, for GRAIL (GRAL) stock?
GRAIL has a consensus price target of $105.00.
What is the current price for GRAIL (GRAL)?
The stock price for GRAIL (NASDAQ: GRAL) is $99.54 last updated January 15, 2026 at 12:03 PM EST.
Does GRAIL (GRAL) pay a dividend?
There are no upcoming dividends for GRAIL.
When is GRAIL (NASDAQ:GRAL) reporting earnings?
GRAIL does not have any upcoming earnings scheduled.
Is GRAIL (GRAL) going to split?
There is no upcoming split for GRAIL.
What sector and industry does GRAIL (GRAL) operate in?
GRAIL is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
